BMO Capital Starts Tranzyme (TZYM) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq ends down as chipmakers fall and bank earnings roll in
- Oil prices settle mixed, focus on US-Russia diesel deal, Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
Tweet
Share
E-mailGet Alerts TZYM Hot Sheet
Price: $0.48 --0%
Rating Summary:
3 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 17 | New: 36
Rating Summary:
3 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 17 | New: 36
Join SI Premium – FREE
BMO Capital initiates coverage on Tranzyme (NASDAQ: TZYM) with an Outperform. PT $6.00.
For an analyst ratings summary and ratings history on Tranzyme click here. For more ratings news on Tranzyme click here.
Shares of Tranzyme closed at $2.90 yesterday.
For an analyst ratings summary and ratings history on Tranzyme click here. For more ratings news on Tranzyme click here.
Shares of Tranzyme closed at $2.90 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Maxim Group Starts Kyntra Bio (KYNB) at Buy
- Brean Capital Starts CoastalSouth Bancshares Inc (COSO) at Buy
- Ladenburg Thalmann Starts Compass Diversified (CODI) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
BMO CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
